Bortezomib Treatment Produces Nocifensive Behavior and Changes in the Expression of TRPV1, CGRP, and Substance P in the Rat DRG, Spinal Cord, and Sciatic Nerve
Figure 10
Double labeling immunofluorescence for TRPV1/CGRP in sciatic nerve from control (ctrl) (a–c) and chronically BTZ-treated rats (d–f). (c) and (f) represent the composite images obtained by overlay of (a)-(b) and (d)-(e), respectively. Scale bar = 10 μm.